News
London "is number one European city in life sciences"
A new report says that London is the top city in Europe for the life sciences industry, and ranks third worldwide after Boston and New York in the US.
News
Neurogene shares fall on Rett syndrome gene therapy data
Neurogene has reported encouraging efficacy results with its gene therapy for rare genetic disorder Rett syndrome, but investors' concerns about safety seem to be weighing on its share pric
News
Merck drug for rare tumour hits phase 3 target
Merck KGaA is shaping up to take on Daiichi Sankyo and Ono Pharma in the market for tenosynovial giant cell tumour (TGCT) therapies after its drug candidate pimicotinib cleared a phase 3 tr
R&D
Growing threat of AMR: UN calls for urgent global action
In response to the rise of AMR, world leaders recently convened at the United Nations General Assembly to forge a landmark commitment, setting ambitious targets and funding initiatives to c
News
Chasing $80bn sales target, AZ unveils $3.5bn US investment
AstraZeneca plans to invest a whopping $3.5 billion to expand its R&D and manufacturing operations in the US by 2026, as part of a drive to raise its revenues to $80 billion by the end
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
